Fulcrum Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
FULC Nasdaq 2830 www.fulcrumtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference - Mar 4th, 2025 9:05 pm
Fulcrum Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Feb 26th, 2025 10:31 am
Fulcrum Therapeutics Inc (FULC) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Feb 26th, 2025 7:04 am
Q4 2024 Fulcrum Therapeutics Inc Earnings Call - Feb 26th, 2025 6:28 am
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024 - Feb 25th, 2025 12:00 pm
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET - Feb 18th, 2025 9:05 pm
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb 7th, 2025 9:30 pm
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Feb 6th, 2025 9:05 pm
Fulcrum Therapeutics Insider Ups Holding During Year - Feb 4th, 2025 3:15 pm
Fulcrum Therapeutics (NASDAQ:FULC) shareholders have endured a 77% loss from investing in the stock three years ago - Dec 19th, 2024 5:07 pm
Fulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why - Nov 28th, 2024 5:00 pm
Fulcrum Therapeutics to Participate in Upcoming December Conferences - Nov 26th, 2024 9:05 pm
Fulcrum Therapeutics Third Quarter 2024 Earnings: US$0.35 loss per share (vs US$0.39 loss in 3Q 2023) - Nov 15th, 2024 12:28 pm
Fulcrum Therapeutics Inc (FULC) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst ... - Nov 14th, 2024 7:07 am
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024 - Nov 13th, 2024 12:00 pm
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference - Nov 12th, 2024 9:05 pm
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET - Nov 6th, 2024 1:00 pm
Fulcrum Before Q3 Earnings: How Should Investors Play the Stock? - Oct 25th, 2024 1:55 pm
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow - Oct 21st, 2024 2:07 pm
Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up - Oct 18th, 2024 12:00 pm